News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cox John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Disposed/sold 341 shares
@ $0
Disposed/sold 683 options to buy
@ $6.6439, valued at
$4.5k
Disposed/sold 683 options to buy
@ $4.9984, valued at
$3.4k
|
|
| 05/27/2022 |
4
| Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $0.7632, valued at
$6.8k
|
|
| 06/28/2021 |
4
| Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $9.97, valued at
$88.6k
|
|
| 12/10/2020 |
4
| Cox John (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Converted 4,444 shares
@ $0
Converted 4,444 convertible preferred
@ $0 |
|
| 12/03/2020 |
3
| Cox John (Director) has filed a Form 3 on Sigilon Therapeutics, Inc. |
| 03/26/2020 |
4
| Cox John (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 1,858 shares
@ $96.72, valued at
$179.7k
|
|
| 03/20/2020 |
4
| Cox John (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Sold 24,533 shares
@ $95.13, valued at
$2.3M
Sold 1,187 shares
@ $96.45, valued at
$114.5k
Sold 1,016 shares
@ $97.17, valued at
$98.7k
Exercised 14,000 options to buy
@ $12.91, valued at
$180.7k
Exercised 3,632 options to buy
@ $41.19, valued at
$149.6k
Exercised 3,366 options to buy
@ $26.12, valued at
$87.9k
Exercised 2,434 options to buy
@ $38.76, valued at
$94.3k
Exercised 3,304 options to buy
@ $42.07, valued at
$139k
|
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| Cox John (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 923 shares
@ $0
Granted 2,109 options to buy
@ $67.71, valued at
$142.8k
|
|
| 05/17/2018 |
4
| Cox John (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 1,486 shares
@ $0
Granted 3,304 options to buy
@ $42.07, valued at
$139k
|
|
| 03/08/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 185,094 shares
@ $0
Disposed/sold 136,364 restricted stock units
@ $0
Disposed/sold 48,678 restricted stock units
@ $0
Disposed/sold 48,230 options to buy
@ $7.82, valued at
$377.2k
Disposed/sold 387,366 options to buy
@ $44.51, valued at
$17.2M
Disposed/sold 193,683 options to buy
@ $44.51, valued at
$8.6M
|
|
| 02/26/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 13,973 shares
@ $104.3, valued at
$1.5M
Paid exercise price by delivering 5,794 shares
@ $104.74, valued at
$606.9k
|
|
| 02/15/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 10,819 shares
@ $103.52, valued at
$1.1M
Exercised 24,339 restricted stock units
@ $0 |
|
| 02/13/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 7,672 shares
@ $103.05, valued at
$790.6k
Exercised 18,381 options to buy
@ $9.53, valued at
$175.2k
|
|
| 02/02/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 136,364 restricted stock units
@ $0 |
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2017 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc. |
| 03/27/2017 |
4/A
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc. |
| 03/02/2017 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Granted 211,679 shares
@ $0
Paid exercise price by delivering 3,404 shares
@ $43.42, valued at
$147.8k
Paid exercise price by delivering 3,383 shares
@ $49.56, valued at
$167.7k
Paid exercise price by delivering 8,355 shares
@ $47.76, valued at
$399k
Paid exercise price by delivering 6,986 shares
@ $43.42, valued at
$303.3k
Paid exercise price by delivering 2,641 shares
@ $49.56, valued at
$130.9k
Paid exercise price by delivering 6,436 shares
@ $47.76, valued at
$307.4k
Paid exercise price by delivering 6,726 shares
@ $43.42, valued at
$292k
Granted 48,230 options to buy
@ $7.82, valued at
$377.2k
Granted 18,381 options to buy
@ $9.53, valued at
$175.2k
|
|
| 02/16/2017 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc. |
| 12/22/2016 |
3
| Cox John (CEO) has filed a Form 3 on Bioverativ Inc. |
| 05/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2016 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 1,324 shares
@ $250.77, valued at
$332k
Exercised 4,026 restricted stock units
@ $0 |
|
| 12/04/2013 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Gifted 200 shares
@ $0 |
|
| 05/07/2013 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 866 shares
@ $218.85, valued at
$189.5k
|
|
| 02/26/2013 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,227 shares
@ $164.4, valued at
$201.7k
Exercised 2,598 restricted stock units
@ $0 |
|
| 02/12/2013 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,133 shares
@ $164.44, valued at
$186.3k
Paid exercise price by delivering 1,836 shares
@ $164.44, valued at
$301.9k
Exercised 3,487 restricted stock units
@ $0
Disposed of 536 restricted stock units
@ $0
Exercised 4,692 restricted stock units
@ $0 |
|
| 05/04/2012 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 765 shares
@ $134.26, valued at
$102.7k
|
|
| 02/27/2012 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,085 shares
@ $116.7, valued at
$126.6k
Paid exercise price by delivering 785 shares
@ $116.39, valued at
$91.4k
Paid exercise price by delivering 793 shares
@ $116.39, valued at
$92.3k
Exercised 2,600 restricted stock units
@ $0 |
|
| 11/03/2011 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 2,175 shares
@ $114.37, valued at
$248.8k
Exercised 2,175 options to buy
@ $72.87, valued at
$158.5k
|
|
| 05/04/2011 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 765 shares
@ $97.99, valued at
$75k
|
|
| 04/25/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2011 |
4
| Cox John (EVP Pharmaceutical Oper & Tech) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 6,900 shares
@ $78, valued at
$538.2k
Exercised 6,900 options to buy
@ $47.92, valued at
$330.6k
|
|
|
|
|